⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological Malignancies

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological Malignancies

Official Title: Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological Malignancies

Study ID: NCT02164071

Study Description

Brief Summary: The elderly comprise the most prevalent population in oncology practice. The available evidence suggests that old patients are undertreated patients, mainly because of their advanced age, regardless of whether they are highly functional patients, they do not present co morbidities and could benefit from oncology therapies. Treatment planning must consider several health indices that are useful when it comes to detecting geriatric problems that could affect the patient's treatment experience. The complete comprehensive geriatric evaluation stands out as cornerstone among other validated tools that do not work as isolated instruments; however, its length and complexity may hinder its routine use in clinical practice for decision making. The purpose of this study is to validate a comprehensive health status assessment scale in elderly patients (≥65 years) with hematological malignancies that, while integrating the essential dimensions of geriatric assessment and, with the same precision as the currently available valid tools, is shorter and easier to apply, so it can be incorporated into the daily practice and that aids in clinical decision making objectively. If so, this information would help identify patients that could benefit from a specific oncology treatment, thus contributing to developing a targeted intervention plan and to optimizing the cancer results in this patient population.

Detailed Description:

Eligibility

Minimum Age: 65 Years

Eligible Ages: OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Hospital Txagorritxu, Vitoria, Alava, Spain

Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain

Hospital Sant Joan de Deu, Espluges De Llobregat, Barcelona, Spain

Hospital Duran I Reynals, L'Hospitalet de Llobregat, Barcelona, Spain

Hospital Parc Tauli, Sabadell, Barcelona, Spain

Hospital de Donostia, San Sebastian, Guipuzcoa, Spain

Hospital U. Puerta de Hierro, Majadahonda, Madrid, Spain

C.H. Navarra, Pamplona, Navarra, Spain

Hospital Universitario de Canarias, San Cristobal de la Laguna, Tenerife, Spain

Hospital Ntra. Sra. La Candelaria, Santa Cruz de Tenerife, Tenerife, Spain

Hospital La Ribera, Alzira, Valencia, Spain

Hospital Germans Trias i Pujol, Badalona, , Spain

Hospital Vall d'Hebron, Barcelona, , Spain

Hospital Clinic, Barcelona, , Spain

Hospital Virgen de las Nieves, Granada, , Spain

C.H. Universitario A Coruna, La Coruna, , Spain

Arnau de Vilanova, Lerida, , Spain

Hospital U. Gregorio Maranon, Madrid, , Spain

Hospital Infanta Leonor, Madrid, , Spain

Hospital de Segovia, Segovia, , Spain

Hospital Virgen del Rocio, Sevilla, , Spain

Hospital La Fe, Valencia, , Spain

Contact Details

Name: Jose Luis Garcia, PhD

Affiliation: Celgene

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: